KUALA LUMPUR, April 30 (Bernama) -- Guangzhou Link Health Pharma Co Ltd (Link Health) and George Clinical Pty Ltd (George Clinical) have signed a term sheet to enter into a strategic agreement to establish an independent joint venture clinical development company called Link-George Clinical Research Co Ltd (Link-George).
Link-George will deliver clinical trials for Link Health and related companies that it has entered into licensing deals with.
According to a statement, the plan is for Link-George to launch six clinical trials this year and this is expected to grow as Link Health’s in-licensed portfolio expands.
Link-George will be majority owned by Link Health and operationally led by George Clinical with a board that comprises representatives from both Link Health and George Clinical.
Link Health chief executive officer (CEO) and founder, Dr Song Yan, said: “To speed up the pace of going global, Link Health has been expanding business in North America, Europe, Asia-Pacific and other regions.
“Through this joint venture, Link Health and George Clinical will complement each other’s advantages in the fields of drug-ability evaluation, medical writing, medical statistics, clinical protocol design, real-world research, and jointly provide Link Health and its customers with end-to-end integrated solutions.”
George Clinical CEO James Cheong said: “We are very excited to enter into this joint venture with Link Health as part of a novel platform providing a one-stop service for in-licensing, clinical development, marketing authorisation and commercialisation. This will enable both companies to further optimise the tremendous growth in the pharmaceutical industry in China.”
-- BERNAMA
No comments:
Post a Comment